WuXi AppTec Cashes Out HK$3.92 Billion from WuXi XDC Stake, Disposal Gains to Boost 2026 Profit by Over RMB 3.1 Billion

Nashnova编辑部
今天发布阅读约 9 分钟

WuXi AppTec (603259.SH) sold 53.52 million shares of WuXi XDC (02268.HK) via block trade on August 26 for roughly HK$3.92 billion, booking a pre-tax gain of about RMB 3.14 billion — while its blockbuster H1 results prompted a full-year guidance upgrade, shifting market focus to the remaining stake.

01

How large was this disposal — and how much did it earn?

WuXi AppTec sold 53.524 million shares of WuXi XDC (02268.HK) through a block trade, representing about 4.23% of XDC's total share capital.
The transaction raised roughly HK$3.92 billion (before fees); the preliminary investment gain is about RMB 3.143 billion (pre-tax).
This means → the one-off gain alone exceeds 10% of WuXi AppTec's full-year 2025 audited net profit — a single trade that visibly lifts the bottom line.
The company noted the final figure is subject to year-end audit confirmation, but the order of magnitude is clear.
02

Where will the cash go?

WuXi AppTec said the proceeds will fund three priorities: doubling down on core operations, accelerating global capacity build-out, and talent retention.
It also cited "capital-structure optimization and shareholder returns."
In plain terms = selling a subsidiary stake to bring cash home — part goes back into expanding capacity, part may fund buybacks or dividends. The logic: convert a financial investment into operating resources and shareholder returns.
03

How strong was the first-half report card?

H1 2026 revenue hit RMB 28.90 billion, up 38.93% year-on-year; net profit attributable to shareholders reached RMB 11.08 billion, up 29.43%.
Adjusted net profit (excluding non-recurring items) was RMB 10.57 billion, up 89.39% — This means → stripping out one-offs, core operating profit nearly doubled, underscoring the quality of the beat.
By segment: Chemistry services — RMB 24.99 billion (+53.3%) — was the biggest growth engine; Testing — RMB 2.48 billion (+31.5%); Biology — RMB 1.39 billion (+11.2%).
Backlog stood at RMB 66.43 billion, up 25.2% — This reflects accelerating outsourcing demand from downstream clients.
04

How much was full-year guidance raised?

Full-year revenue guidance was lifted from RMB 51.3–53.0 billion to RMB 58.5–60.5 billion — an upgrade of more than 14%.
Continuing-operations revenue growth guidance jumped from 18%–22% to 35%–39%.
In plain terms = the targets set at the start of the year were already outdated by mid-year — the business outran its own goalposts.
The company also declared an interim dividend of RMB 0.51 per share (pre-tax).
05

What is the market watching next?

WuXi AppTec's A-share price gained roughly 79.59% from early January to August 27, hitting an intra-period high of RMB 173.6.
The guidance upgrade and block disposal landed almost simultaneously — This reflects a deliberate choice to monetize a financial investment at peak share price and peak earnings momentum.
The key question going forward: how large is WuXi AppTec's remaining stake in WuXi XDC, and whether further disposals are planned.

市场有风险,内容仅供研究参考,不构成投资建议。